• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 439516 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416515090 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416515090 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Valeant Pharmaceuticals International: 52-Week High Recently Eclipsed (VRX)

Published on Fri, 02/08/2013 - 15:25
By Mallory Stone

Valeant Pharmaceuticals International (NYSE:VRX) traded today at a new 52-week high of $67.98. This new high was reached on below average trading volume as 576,000 shares traded hands, while the average 30-day volume is approximately 1.4 million shares.

Valeant Pharmaceuticals International share prices have moved between a 52-week high of $67.98 and a 52-week low of $42.47 and are now trading 59% above that low price at $67.71 per share. The 200-day and 50-day moving averages have moved 0.43% higher and 1.50% higher over the past week, respectively.

Valeant Pharmaceuticals International has overhead space with shares priced $67.71, or 6.1% below the average consensus analyst price target of $72.13. The stock should find initial support at its 50-day moving average (MA) of $61.45 and further support at its 200-day MA of $54.13.

Valeant Pharmaceuticals International is a research-based, specialty pharmaceutical company that markets its products worldwide. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products, focusing on products in the areas of infectious disease, neurology, and dermatology.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Watch for Continued Losses in Shares of ...

Shares of SAIFUN SEMICONDUCTOR (NASDAQ:SFUN) traded at a new 52-week low today of $8.11 ...

Watch for Continued Gains in Shares of S...

SBA Communications (NASDAQ:SBAC) traded today at a new 52-week high of $116.11. So far ...

Shares of Sprint Nextel Fall to a New 52...

Shares of Sprint Nextel (NYSE:S) traded today at $4.64, breaking its 52-week low. This ...

Shares of Rentech Have Fallen Below Prev...

Rentech (AMEX:RTK) traded today at a new 52-week low of $1.35. Approximately 1.1 milli ...

Watch for Continued Gains in Shares of R...

Shares of Ross Stores (NASDAQ:ROST) traded today at $83.50, breaking its 52-week high. ...

Shares of Polo Ralph Lauren Rise to a Ne...

Polo Ralph Lauren (NYSE:RL) traded at a new 52-week high today of $181.35. So far toda ...

Watch for Continued Gains in Shares of R...

Shares of RF Micro Devices (NASDAQ:RFMD) traded at a new 52-week high today of $14.28. ...

Everest Re Group: 52-Week High Recently ...

Everest Re Group (NYSE:RE) traded at a new 52-week high today of $174.55. Approximatel ...